NCT05271591View on ClinicalTrials.gov

Generalizability of REDUCE-IT Results to People of South Asian Descent With Atherosclerotic Cardiovascular Disease in Canada (REDUCE-IT Canada SA)

CompletedOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

March 5, 2022

Primary Completion Date

April 9, 2022

Study Completion Date

April 9, 2022

Conditions
Cardiovascular DiseasesAtherosclerotic Cardiovascular DiseaseMyocardial InfarctionCoronary Heart Disease
Trial Locations (5)

L1Z 0B1

Scarborough Health Network, Ajax

L3R 7B4

Fenton Medical Centre, Markham

M6B1N6

North York Diagnostic and Cardiac Centre, North York

M1B 5K9

Legacy Medical Centre, Scarborough Village

M1S4N6

Diagnostic Assessment Centre, Scarborough Village

Sponsors

Collaborators (1)

HLS Therapeutics, Inc
All Listed Sponsors
collaborator

HLS Therapeutics, Inc

UNKNOWN

lead

Canadian Medical and Surgical Knowledge Translation Research Group

OTHER

NCT05271591 - Generalizability of REDUCE-IT Results to People of South Asian Descent With Atherosclerotic Cardiovascular Disease in Canada (REDUCE-IT Canada SA) | Biotech Hunter | Biotech Hunter